House
GuidelinesCalculatorsPricingBlog
Ask House ↗
Guidelines↗Calculators↗Pricing↗Blog↗
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
Back to guidelines
Palliative care

Approach to managing Bleeding in a cancer patient

NCG · 2021 edition / updateSource checked 29 October 2026
Read the source publication
House clinical summary

Scope

The National Cancer Grid’s May 2021 palliative-care guidance addresses bleeding from malignant lesions and internal organs, including preparation for catastrophic haemorrhage near the end of life. Assessment considers reversibility, disease status, functional state and the patient’s preferences. This summary covers clear assessment, local-care and supportive-care recommendations. It does not reconstruct every branch of the flowcharts or reproduce the medication tables as a complete prescribing protocol.

Written by House with AI assistance · AI-assisted source check 29 October 2026.

This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.

Assess severity, causes and goals

  • Evaluate bleeding severity, the underlying disease, the patient’s condition and patient/family treatment preferences. Review contributing medicines, including NSAIDs, antiplatelets, anticoagulants and chemotherapy, alongside coagulopathy and thrombocytopenia. [1]
  • The initial pathway includes haemodynamic assessment, blood count and platelets, prothrombin time, liver and renal function, and reversible causes. Consider stopping medicines that exacerbate bleeding after weighing risks and benefits. [1]
  • Discuss intervention in relation to agreed goals of care. The pathway includes endovascular treatment, haemostatic radiotherapy and surgical control when these align with the patient’s goals. [1]

Reduce trauma and control local symptoms

  • Malignant wounds bleed easily during dressing changes. Use non-adherent dressings and gentle irrigation, and teach patients or carers how to handle dressings with less trauma. [1]
  • Listed topical haemostatic options include calcium alginate, sucralfate paste and tranexamic-acid preparations. The source cautions that topical adrenaline can cause ischaemic necrosis. [1]
  • Assess pain regularly and provide analgesia according to severity, using the separate NCG pain guidance. Treat wound infection according to institutional antibiotic protocols. [1]

Consider specialist and systemic measures

  • For potentially reversible pulmonary bleeding, obtain specialist assessment. The source describes bronchoscopic local control, thoracic irradiation for longer effect and bronchial-artery embolisation as options selected according to the bleeding site and situation. [1]
  • Lower gastrointestinal bleeding that is reversible warrants specialist care. For prostatic bleeding, the source describes catheter-based measures and referral if control is not achieved; vesical bleeding is deferred to the separate NCG urinary-bleeding guideline. [1]
  • Use the patient’s performance status, ongoing cancer treatment and bleeding severity when considering therapeutic platelet transfusion. The source pairs it with correction of coagulation abnormalities and review of anticoagulant and antiplatelet treatment. [1]
  • In massive haemoptysis, positioning on the bleeding side is described to reduce aspiration into the unaffected lung. [1]

Plan for irreversible catastrophic bleeding

  • For a realistic risk of catastrophic end-of-life bleeding, agree an anticipatory plan. Balance the probability of the event, including prior sentinel bleeding, against the distress that discussing it may cause. [1]
  • Document goals, preferred place of care, patient/family preferences and whether life support is wanted. Prepare a bedside crisis pack with dark towels or bedding, gloves, instructions, contact details and planned symptom medicines; consider the stability of prefilled medicines. [1]
  • In the source’s specific context of catastrophic bleeding beyond reversal, sedation aims to reduce awareness and distress; opioids are reserved for pain or breathlessness. This is a comfort-care pathway after goals have been established. [1]
  • Preserve privacy and dignity, provide emergency telephone support, and support the family before and after the event. The guidance also calls for staff debriefing and support for the emotional impact. [1]

Limitations and use

  • This is the May 2021 NCG pathway, not a newly issued 2026 medication protocol. It must not be described as a contemporary comparative review of every haemostatic treatment.
  • The source contains interleaved flowcharts, incomplete text and a questionable nebulized-adrenaline concentration. Detailed haemostatic and sedative doses are excluded; those tables cannot support a complete prescription without a separate verified source.
  • The irreversible catastrophic-bleeding comfort pathway must not be generalized to a reversible major haemorrhage. Performance status alone does not replace assessment of severity, reversibility and the patient’s goals.

This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.

Summary sources

  1. 1
    Approach to managing Bleeding in a cancer patient

    Selected recommendation material consulted

Clinical guideline

Publication details

Issuing organisation
NCG
Resource type
Clinical guideline · House clinical summary
Source setting
India

The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.

On this page

  • Scope
  • Assess severity, causes and goals
  • Reduce trauma and control local symptoms
  • Consider specialist and systemic measures
  • Plan for irreversible catastrophic bleeding
  • Limitations and use
  • Summary sources
  • Publication details
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House